$5.77
-0.11 (-1.87%)

Key Metrics

Market Cap
$69.84M
P/E Ratio
-10.49
EPS
$-0.55
Beta
N/A
Dividend Yield
N/A
ROE
-514.92%
Current Ratio
2.38

Company Information

Industry
Medical Devices

About LENSAR Inc

LENSAR Inc a commercialstage medical device company focuses on designing developing and marketing a femtosecond laser system for the treatment of cataracts and the management of preexisting or surgically induced corneal astigmatism Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes efficiency and reproducibility by providing imaging procedure planning design and precision The company was incorporated in 2004 and is headquartered in Orlando Florida

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-05-08 $1.56 $0.19 +743.2%
2026-03-31 $-0.12 $-0.07 80.7%
2025-11-06 $-0.31 $-0.10 210.0%
2025-08-07 $-0.15 $-0.08 87.5%

Financial Ratios (TTM)

Gross Margin
45.32%
Operating Margin
-28.68%
Net Margin
50.94%
ROA
44.39%
Price to Book
2.86
Price to Sales
1.21